NCT00898430 2013-04-02Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation TherapyVanderbilt-Ingram Cancer CenterTerminated49 enrolled